Anna Roig receives the Albus Award for her project on "Albumin iron-oxide nanocages"
- News 09 October 2017 1917 hits
As already announced in July 2017, on Tuesday 3rd October, Pof. Anna Roig received the Albus Award 2017, by Grifols, to develop her project on "Albumin iron-oxide nanocages". The Awards Ceremony took place at the Grifols Museum, which is located in the same building where the Grifols company started their activities, in 1940.
Every year, the Albus Program gives two Albus Awards of 50,000 € to the best two innovative ideas related to albumin and its role as a therapeutic product. The project proposals are assessed by independent reviewers.
In this year's edition, the two award recipients were Prof. Anna Roig, from the Nanoparticles and Nanocomposites Group (NN) at ICMAB, and Dr. Karl Oettl, from the Medical University of Graz (Austria), for his project on "Effect of albumin redox state on the intracellular redox balance in cell culture".
Anna's project, "Albumin iron-oxide nanocages" aims to investigate if albumin nanocages, consisting of a few units of albumin self-assembled and self-standing, can be formed by using inorganic iron oxide nanoparticles as semi-sacrificial templates. The albumin nanocages could then find application as a nanomedicinal product for imaging and drug delivery.
The Grifols Museum, where the Award Ceremocy was held, shows the most significant milestones that have marked the Grifols company history. The virtual museum website offers a journey through the history of the company which is a world reference in the field of hemathology and hemotherapy.
Related Topics: Staff